We have now shown that hepatic FASN deficiency ameliorated NAFLD and diabetes in Mc4r-KO mice by suppressing DNL, FAO, and gluconeogenesis and improving hepatic insulin signaling without inducing hypertriglyceridemia. This evidence concerns the gene DNASE2 and diabetes mellitus.